NOT_YET_RECRUITING
I'm interested ...!!
Adherence to Otezla
Most people with psoriasis have very limited disease, yet that disease may still have a large impact on their lives. While limited psoriasis may be amenable to topical treatment, patients are exceptionally poorly adherent to topical treatment, especially over the long run.
Conditions:
🦠 Psoriasis
🗓️ Study Start (Actual) July 2024
🗓️ Primary Completion (Estimated) December 2024
✅ Study Completion (Estimated) February 2025
👥 Enrollment (Estimated) 84
🔬 Study Type INTERVENTIONAL
📊 Phase EARLY_PHASE1
Locations:
📍 Winston-Salem, North Carolina, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * Adult 18 years or older
    • * Diagnosis of mild psoriasis with Otezla recommendation
    • * Non-pregnant
    • * English speaking

    Exclusion Criteria:

    • * Under 18 years of age
    • * Not diagnosis of mild psoriasis
    • * Pregnant
    • * Non-English speaking
Ages Eligible for Study: 18 Years to 85 Years (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 13 October 2022
  • First Submitted that Met QC Criteria 26 October 2022
  • First Posted 1 November 2022

Study Record Updates

  • Last Update Submitted that Met QC Criteria 22 May 2024
  • Last Update Posted 23 May 2024
  • Last Verified May 2024
I'm interested ...!!